Literature DB >> 32291390

SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.

Zhipeng Du1,2, Zhuoying Lin1,2, Zhihui Wang1,2, Danfei Liu1,2, Dean Tian3,4, Limin Xia5,6.   

Abstract

Sparc/osteonectin, cwcv, and kazal-like domain proteoglycan 1 (SPOCK1) is a matricellular protein which regulates cell proliferation, invasion, and survival but the function of SPOCK1 in liver fibrosis is obscure. In this study, we found that SPOCK1 expression increased significantly in fibrotic liver tissues and activated primary rat hepatic stellate cells (R-HSCs). SPOCK1 co-localized with α-smooth muscle actin (α-SMA) in the cytoplasm. Mechanistically, we found platelet-derived growth factor-BB (PDGF-BB) induced SPOCK1 expression by activating the PI3K/Akt/forkhead box M1 (FoxM1) signaling pathway. Intracellular SPOCK1 downregulation decreased the HSC activation, proliferation, and migration induced by PDGF-BB. Furthermore, intracellular SPOCK1 overexpression or recombinant SPOCK1 treatment promoted HSC activation, proliferation, and migration by activating the PI3K/Akt signaling pathway. Co-immunoprecipitation, double immunofluorescence staining indicated that SPOCK1 interacted with integrin α5β1, and neutralization of integrin α5β1 significantly reduced the role of recombinant SPOCK1 in HSCs. In vivo HSC-specific SPOCK1 knockdown following lentivirus administration dramatically ameliorated thioacetamide (TAA)-induced collagen deposition in rat livers. Collectively, our study indicates that SPOCK1 is crucial for hepatic fibrosis and it might be a promising therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32291390     DOI: 10.1038/s41374-020-0425-4

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  41 in total

Review 1.  Testican-1: a differentially expressed proteoglycan with protease inhibiting activities.

Authors:  Cora-Jean S Edgell; Mohammad A BaSalamah; Henry S Marr
Journal:  Int Rev Cytol       Date:  2004

Review 2.  The PDGF system and its antagonists in liver fibrosis.

Authors:  Erawan Borkham-Kamphorst; Ralf Weiskirchen
Journal:  Cytokine Growth Factor Rev       Date:  2015-10-30       Impact factor: 7.638

Review 3.  Burden of liver diseases in the world.

Authors:  Sumeet K Asrani; Harshad Devarbhavi; John Eaton; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-09-26       Impact factor: 25.083

Review 4.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

Review 5.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

Review 6.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 7.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 8.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

9.  Matricellular proteins: multifaceted extracellular regulators in tumor dormancy.

Authors:  Tiantian Wu; Gaoliang Ouyang
Journal:  Protein Cell       Date:  2014-04       Impact factor: 14.870

10.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.

Authors:  Christine C Hsu; Juliane S Troeger; Ingmar Mederacke; Peter Huebener; Xueru Mu; Dianne H Dapito; Jean-Philippe Pradere; Robert F Schwabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  8 in total

1.  FOXM1 Promotes Head and Neck Squamous Cell Carcinoma via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis.

Authors:  Xiao Ma; Hong Zhang; Qian Li; Erik Schiferle; Yao Qin; Suifang Xiao; Tiancheng Li
Journal:  Front Oncol       Date:  2021-08-10       Impact factor: 6.244

2.  Assessment of the prognostic value of SPOCK1 in clear cell renal cell carcinoma: a bioinformatics analysis.

Authors:  Jie Chen; Ziqi Ye; Lulu Liu; Bixia Xuan
Journal:  Transl Androl Urol       Date:  2022-04

3.  High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis.

Authors:  Xiangke Pu; Danni Deng; Chaoyi Chu; Tianle Zhou; Jianhong Liu
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

4.  SPOCK1 Promotes the Development of Hepatocellular Carcinoma.

Authors:  Lóránd Váncza; Katalin Karászi; Bálint Péterfia; Lilla Turiák; Katalin Dezső; Anna Sebestyén; Andrea Reszegi; Gábor Petővári; András Kiss; Zsuzsanna Schaff; Kornélia Baghy; Ilona Kovalszky
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

5.  Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments.

Authors:  Shuhui Wang; Zheng Huang; Yu Lei; Xu Han; Dean Tian; Jin Gong; Mei Liu
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

6.  The Pro-Fibrotic Response to Lens Injury Is Signaled in a PI3K Isoform-Specific Manner.

Authors:  A Sue Menko; Janice L Walker
Journal:  Biomolecules       Date:  2022-08-25

7.  EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.

Authors:  Zhipeng Du; Mei Liu; Zhihui Wang; Zhuoying Lin; Yangyang Feng; Dean Tian; Limin Xia
Journal:  Cell Prolif       Date:  2021-05-24       Impact factor: 6.831

8.  Calcium and integrin binding protein 1 (CIB1) induces myocardial fibrosis in myocardial infarction via regulating the PI3K/Akt pathway.

Authors:  Guangquan Hu; Xiaojie Ding; Feng Gao; Jiehua Li
Journal:  Exp Anim       Date:  2021-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.